The General Hospital of Central Theater Command
9
2
2
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 9 trials
100.0%
+13.5% vs industry average
22%
2 trials in Phase 3/4
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (9)
Efficacy and Safety of Early Combined Therapy With PCSK9 Inhibitors and Statins in Acute Ischemic Stroke
Role: collaborator
Efficacy Comparison of DExamethasone Intravitreal Implant Combined With Aflibercept Versus Aflibercept Monotherapy in Treatment-naïve Inflammatory Diabetic Macular Edema Patients
Role: collaborator
The Dose Range of Remimazolam Besylate in Different Age Groups
Role: collaborator
To Evaluate the Clinical Efficacy and Safety of Recombinant Human Interferon ω Spray in Treatment of Viral Upper Respiratory Tract Infection in Children
Role: collaborator
Improved Bowel Preparation Method for Colonoscopy Based on Different Risk Stratification
Role: collaborator
Registry of Multimodality Treatment for Brain Arteriovenous Malformation in Mainland China
Role: collaborator
Multi-center Validation of a Deep Learning Based Bowel Preparation Evaluation System
Role: collaborator
Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Severe Corona Virus Disease 2019 (COVID-19)
Role: collaborator
Efficacy and Safety of "Treat-and-Extend" Regimen Versus "Pro Re Nata" of Conbercept in Age-related Macular Degeneration
Role: collaborator
All 9 trials loaded